-
Mashup Score: 6
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 2
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, NeurologyTweet-
New study shows stroke rates are rising, with more Black Americans dying at home or arriving DOA at hospitals. Experts link this to lack of hospice services and general care. @UW @AANMember #NeuroTwitter 🧠 https://t.co/IF3XcgpujY https://t.co/H3kiLl5x5l
-
-
Mashup Score: 6
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, NeurologyTweet-
President Natalia Rost, MD, FAAN, shares her journey from founding the first AAN Student Interest Group in Neurology, to specializing in stroke, and serving on many AAN committees and initiatives. @harvardmed @AANMember #NeuroTwitter https://t.co/2nS3IB0pwy https://t.co/YZhShokc43
-
-
Mashup Score: 2
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, NeurologyTweet-
🧠 Two observational analyses found reduced risk for Alzheimer’s in those taking GLP-1 receptor agonists. Experts say these findings need confirmation in randomized phase 3 trials. @UFMedicine @AANMember #NeuroTwitter https://t.co/MSVdtO5JbT https://t.co/URLFdNj84z
-
-
Mashup Score: 4
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, NeurologyTweet-
🧠 Three or more neurology drugs have garnered expedited FDA approvals, sometimes conflicting with advisory panel recommendations. Experts call for more attention to the process between FDA panelists and industry. @washumedicine @AANMember #NeuroTwitter https://t.co/KEV5EQNMbM https://t.co/sOhx2IFjDH
-
-
Mashup Score: 13Advances in cell therapies for Parkinson’s, GLP-1 agonists and dementia risk, FDA accelerated approvals for neurology drugs - 3 day(s) ago
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about early studies finding dopamine cellular therapies were safe and tolerable for patients with Parkinson’s, use of GLP-1 agonists were associated with reduced dementia risks, and the FDA use of accelerated approvals for several neurology drugs are under scrutiny.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet-
🧠 The May 15 issue of Neurology Today is live! Dr. Safdieh recaps early data on dopamine cell therapy for Parkinson’s, GLP-1 agonists linked to lower dementia risk, and FDA fast-track approvals under review. Listen to Neurology Today in 5 now! @AANMember https://t.co/yePVFwtX8x https://t.co/uvz8UzApnA
-
-
Mashup Score: 2
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, NeurologyTweet-
🚗 People are talking about this story: Join the conversation about AAN’s updated statement on epilepsy & driving calls for individualized risk assessments and seizure-free intervals of 3+ months. @AANMember #NeuroTwitter https://t.co/hXsW7hMcgk https://t.co/pFKbstGejh
-
-
Mashup Score: 11
This cross-sectional study examines findings from second, independent clinical evaluations of patients initially diagnosed with an alleged “mystery” neurological illness in New Brunswick, Canada, to determine whether there is evidence of such a disease.
Source: jamanetwork.comCategories: General Medicine News, NeurologyTweet-
Via @JAMANeuro: A study finds no evidence of a new neurological disease in New Brunswick. Well-known conditions were identified, stressing the need for second opinions and multidisciplinary support. @AANMember #NeuroTwitter 💉 https://t.co/HXWOtYfi33 https://t.co/JJV8U77O0L
-
-
Mashup Score: 10Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder - 4 day(s) ago
This randomized clinical trial investigates if treatment with fremanezumab compared with placebo leads to improvements in migraine and depressive symptoms in patients with migraine and comorbid major depressive disorder.
Source: jamanetwork.comCategories: General Medicine News, NeurologyTweet-
Fremanezumab trial shows significant reduction in monthly migraine days and depressive symptoms for patients with migraine and major depressive disorder. @JAMANeuro @AANMember #NeuroTwitter 💉 https://t.co/dHAsYyZZV6 https://t.co/PJYFZV9j8q
-
-
Mashup Score: 5
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, NeurologyTweet-
Researchers found high concentrations of microplastics in the brain—small enough to cross the blood-brain barrier—using transmission electron microscopy. This discovery raises important questions about neurological health. @unmcop @AANMember #NeuroTwitter https://t.co/VmFYd0WOh7 https://t.co/EOTz0FvMo7
-
Gantenerumab trial suggests potential delay in symptoms for dominantly inherited Alzheimer’s, but experts urge caution due to study limitations. @washumedicine @AANMember #NeuroTwitter 💉 https://t.co/L7mFvco7ll https://t.co/hDK8Z6C2gW